Understanding how cells divide and what goes wrong in cancer
Investigating the Cell Division Machinery
This study is looking at how cells divide and the proteins that help make sure this process goes smoothly, with the hope of finding new ways to treat cancer by identifying proteins that could be targeted if cell division goes wrong.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11041152 on NIH RePORTER |
What this research studies
This research investigates the intricate processes involved in cell division, focusing on how proteins interact and regulate this critical function. By using advanced techniques from cell biology, molecular biology, and computational biology, the team aims to identify new proteins that play essential roles in ensuring accurate cell division. The study also explores potential inhibitors that could disrupt faulty cell division, which is often linked to cancer. Through these efforts, the research seeks to uncover mechanisms that could lead to new cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cancers associated with chromosomal instability or aneuploidy.
Not a fit: Patients with cancers that do not involve cell division abnormalities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapies that target cancer by correcting the misregulation of cell division.
How similar studies have performed: Other research has shown promise in targeting cell division mechanisms for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Torres, Jorge — University of California Los Angeles
- Study coordinator: Torres, Jorge
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.